Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases
S.-W. Huang, Y.-G. Lai, H.-T. Liao, C.-L. Chang, R.-Y. Ma, Y.-H. Chen, Y.-H. Liou, Z.-Q. Wu, Y.-C. Wu, K.-J. Liu, Y.-T. Huang, J.-L. Yang, M.-S. Dai, N.-S. Liao
This study shows that autologous NK cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases in a mouse model and a clinical trial.
bioRxiv · May 3, 2024Immunology